About ClavystBio
ClavystBio is a Healthcare company based in Singapore (Singapore). ClavystBio is engaged in life sciences investment and venture building. It operates on a Professional Services and Two-Sided Marketplace model. ClavystBio offers products and services including Venture Building and Partnership Development. Its focus areas include Biotechnology and Life Sciences Investment.
Company details
ClavystBio is focused on accelerating life science breakthroughs into tangible health impacts. The company is involved in launching and growing global life sciences companies by backing innovative science and enabling novel solutions. As a venture builder, it fosters company creation and growth through active incubation and investment. Additionally, partnerships with public and private entities are forged to catalyze commercialization and talent development within the sector.
- Headquarters Singapore, Singapore
- SectorsHealthcare
- Website clavystbio.com
- Social LinkedIn
Products & Services of ClavystBio
ClavystBio offers a comprehensive portfolio of products and services, including Venture Building and Partnership Development.
Company creation and growth are fostered through incubation.
Public and private partnerships are built for commercialization.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as ClavystBio (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Clavystbio
Complete news archive for ClavystBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ClavystBio
ClavystBio is headquartered in Singapore, Singapore.
ClavystBio is focused on accelerating life science breakthroughs into tangible health impacts. The company is involved in launching and growing global life sciences companies by backing innovative science and enabling novel solutions. As a venture builder, it fosters company creation and growth through active incubation and investment. Additionally, partnerships with public and private entities are forged to catalyze commercialization and talent development within the sector.
ClavystBio offers Venture Building and Partnership Development.